DUBLIN, April 30, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the pharmaceutical industry, "Impact of the Coronavirus on Cough & Cold Medications - GlaxoSmithKline, Vernalis, Pfizer, Taro Pharmaceuticals and Bayer Seeing Increased Demand for Their OTC Products"
In most cases, mild symptoms of COVID-19 which can include a high temperature and persistent cough, can be treated with over-the-counter medications without the need for hospitalization. Authorities have advised people with mild symptoms to self-isolate in their homes and avoid going out in public or to healthcare facilities where they could risk infecting vulnerable people.
In response to this, many consumers have started stocking up on over -the-counter cold and flu medications, cough suppressants, lozenges and painkillers in order to be prepared in case they begin to experience symptoms of COVID-19. Many pharmaceutical companies are seeing increased demand for their over-the-counter products including GlaxoSmithKline, Vernalis, Pfizer, Taro Pharmaceuticals and Bayer.
To see the full article and a list of related reports on the market, visit "Impact of the Coronavirus on Cough & Cold Medications - GlaxoSmithKline, Vernalis, Pfizer, Taro Pharmaceuticals and Bayer Seeing Increased Demand for Their OTC Products"
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets